Related Experiment Videos
[Antitumor effect of a tumor-cell neuraminidase vaccine]
Abstract:
The effect of neuraminidase vaccine of CBA mouse sarcoma cells caused by simian adenovirus SA7 (C8) on growth parameters of transplanted sarcoma in a syngeneic system was studied. Inoculation of the vaccine was found to inhibit tumor growth. This effect was more marked in a group of animals given tumor cells after preliminary vaccination. There was no correlation between tumor growth parameters and cytotoxic activity of spleen cells assesses in the cytotoxicity test by 51Cr release in the groups of vaccinated and control animals. It is concluded that the treatment of tumor cells with neuraminidase increases their immunogenicity. The cytotoxic activity of spleen cells in vaccinated animals appears earlier and persists longer.
Insights
Neuraminidase vaccine inhibited sarcoma growth in mice. Pre-vaccination enhanced this tumor inhibition, suggesting increased immunogenicity and prolonged spleen cell activity, despite no direct correlation with cytotoxic activity.
Area of Science:
- Immunology
- Oncology
- Vaccine Development
Background:
- Investigating the immunomodulatory effects of vaccines on tumor growth.
- Understanding the role of neuraminidase in altering tumor cell immunogenicity.
Purpose of the Study:
- To evaluate the impact of a neuraminidase vaccine on transplanted sarcoma growth in a syngeneic mouse model.
- To assess the relationship between vaccination, tumor growth parameters, and spleen cell cytotoxic activity.
Main Methods:
- Treatment of CBA mouse sarcoma cells with neuraminidase vaccine.
- Transplantation of treated and untreated tumor cells into syngeneic mice.
- Monitoring tumor growth parameters.
- Assessing spleen cell cytotoxic activity using the 51Cr release assay.
Main Results:
- Neuraminidase vaccine administration inhibited transplanted sarcoma growth.
- Pre-vaccination followed by tumor cell inoculation resulted in more pronounced tumor growth inhibition.
- No significant correlation was observed between tumor growth parameters and spleen cell cytotoxic activity in vaccinated versus control groups.
- Cytotoxic activity of spleen cells appeared earlier and persisted longer in vaccinated animals.
Conclusions:
- Treatment of tumor cells with neuraminidase enhances their immunogenicity.
- Neuraminidase vaccination can inhibit tumor growth, particularly when administered prior to tumor cell exposure.
- The observed anti-tumor effect may involve mechanisms beyond direct spleen cell cytotoxicity.